LOGO
LOGO

AbbVie Q4 Profit Decreases, but beats estimates

By RTTNews Staff Writer   ✉   | Published:   | Follow Us On Google News
rttnewslogo20mar2024

AbbVie (ABBV) released earnings for fourth quarter that decreased from last year but beat the Street estimates.

The company's bottom line totaled $822 million, or $0.46 per share. This compares with $2.473 billion, or $1.38 per share, in last year's fourth quarter.

Excluding items, AbbVie reported adjusted earnings of $4.959 billion or $2.79 per share for the period.

Analysts on average had expected the company to earn $2.77 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter fell 5.4% to $14.301 billion from $15.121 billion last year.

AbbVie earnings at a glance (GAAP) :

-Earnings (Q4): $822 Mln. vs. $2.473 Bln. last year.
-EPS (Q4): $0.46 vs. $1.38 last year.
-Analyst Estimates: $2.77
-Revenue (Q4): $14.301 Bln vs. $15.121 Bln last year.

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update: April 13 – April 17, 2026

April 17, 2026 15:29 ET
The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.